Get started
Work

Cytokine Release Syndrome (CRS) after Chimeric Antigen Receptor (CAR) T Cell Therapy for Relapsed/Refractory (R/R) CLL

Year: 2014
Type: article
Source: Blood
DOI: 10.1182/blood.v124.21.1983.1983
Authors: David L. Porter, Simon F. Lacey, Wei-Ting Hwang, Pamela Shaw, Noelle V. Frey, Anne Chew, Fang Chen, Michael Kalos, Vanessa Gonzalez, Katherine T. Marcucci, Shannon L Maude, Jan J Melenhorst, Manuel Litchman, David T. Teachey, Angela Shen, Alfonso Quintas-Cardamas, Patricia A. Wood, Bruce L. Levine, Carl H. June, Stephan A. Grupp
Institutions: University of Pennsylvania, Abramson Cancer Center, Children's Hospital of Philadelphia, National Institutes of Health, National Heart, Lung, and Blood Institute, Novartis (United States)
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W88695748
FWCI: 0.862
Cites:
Cited by: 7
Related to: 10